Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Recombinant DNA01:09

Recombinant DNA

92.4K
Overview
92.4K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

22.9K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
22.9K
Gene Therapy00:59

Gene Therapy

22.1K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
22.1K
X-Inactivation01:58

X-Inactivation

38.9K
The human X chromosome contains over ten times the number of genes as in the Y chromosome. Since males have only one X chromosome, and females have two, one might expect females to produce twice as many of the proteins, with undesirable results.
38.9K
Introduction to Nuclear Reprogramming01:14

Introduction to Nuclear Reprogramming

1.3K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
1.3K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

1.4K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of a Clinical Decision Support System on Team-Based Clinical Quiz Performance Among Japanese Medical Students: A Pre-Post Pilot Study.

Journal of general and family medicine·2026
Same author

eIF4G2-mediated selective translation of chromatin regulators safeguards adult intestinal stem cell identity and differentiation.

Cell stem cell·2026
Same author

Temporal AI model predicts drivers of cell state trajectories across human aging.

bioRxiv : the preprint server for biology·2026
Same author

Shinya Yamanaka.

Cell reports. Medicine·2026
Same author

Two decades of induced pluripotent stem cell research: From discovery to diverse applications.

Cell stem cell·2026
Same author

Comparison of Myeloablative Busulfan/Cyclophosphamide and Busulfan/Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.

Transplantation and cellular therapy·2025
Same journal

Co-option of lysosomal machinery shapes the evolution of the intracellular photosymbiosis supporting coral reefs.

Cell·2026
Same journal

LEF1 and niche factors determine T cell stemness across chronic diseases.

Cell·2026
Same journal

Recurrent patterns of TOP1-mediated neuronal genomic damage shared by major neurodegenerative disorders.

Cell·2026
Same journal

Four-dimensional molecular mapping from a spatial snapshot reveals the dynamics of hair follicle organogenesis.

Cell·2026
Same journal

Whole-cell particle-based digital twin simulations from 4D lattice light-sheet microscopy data.

Cell·2026
Same journal

Systematic discovery of pathogen effector functions across human pathogens and pathways.

Cell·2026
See all related articles

Related Experiment Video

Updated: May 4, 2026

In vivo Reprogramming of Adult Somatic Cells to Pluripotency by Overexpression of Yamanaka Factors
12:12

In vivo Reprogramming of Adult Somatic Cells to Pluripotency by Overexpression of Yamanaka Factors

Published on: December 17, 2013

14.7K

Shinya Yamanaka.

Shinya Yamanaka

    Cell
    |June 21, 2024
    PubMed
    Summary
    This summary is machine-generated.

    Dr. Shinya Yamanaka pioneered induced pluripotent stem cells (iPS cells) from skin cells. This interview covers iPS cell progress, clinical uses, and global science trends.

    More Related Videos

    De Novo Generation of Somatic Stem Cells by YAP/TAZ
    13:05

    De Novo Generation of Somatic Stem Cells by YAP/TAZ

    Published on: May 7, 2018

    11.3K
    Somatic Genome-Engineered Mouse Models Using In Vivo Microinjection and Electroporation
    08:06

    Somatic Genome-Engineered Mouse Models Using In Vivo Microinjection and Electroporation

    Published on: May 5, 2023

    4.4K

    Related Experiment Videos

    Last Updated: May 4, 2026

    In vivo Reprogramming of Adult Somatic Cells to Pluripotency by Overexpression of Yamanaka Factors
    12:12

    In vivo Reprogramming of Adult Somatic Cells to Pluripotency by Overexpression of Yamanaka Factors

    Published on: December 17, 2013

    14.7K
    De Novo Generation of Somatic Stem Cells by YAP/TAZ
    13:05

    De Novo Generation of Somatic Stem Cells by YAP/TAZ

    Published on: May 7, 2018

    11.3K
    Somatic Genome-Engineered Mouse Models Using In Vivo Microinjection and Electroporation
    08:06

    Somatic Genome-Engineered Mouse Models Using In Vivo Microinjection and Electroporation

    Published on: May 5, 2023

    4.4K

    Area of Science:

    • Stem Cell Biology
    • Regenerative Medicine
    • Molecular Biology

    Background:

    • Dr. Shinya Yamanaka's groundbreaking discovery of reprogramming somatic cells into induced pluripotent stem cells (iPS cells) using defined factors.
    • The foundational work enabling the generation of patient-specific pluripotent stem cells without ethical concerns associated with embryonic stem cells.

    Discussion:

    • Progress in the field of iPS cell technology since its discovery.
    • Challenges and advancements in differentiating iPS cells into various specialized cell types for therapeutic use.
    • The role of Yamanaka factors in cellular reprogramming and potential therapeutic applications.

    Key Insights:

    • iPS cell technology offers a powerful tool for disease modeling and drug screening.
    • Significant strides have been made in understanding the molecular mechanisms underlying iPS cell induction.
    • The potential for personalized regenerative medicine strategies using patient-derived iPS cells.

    Outlook:

    • Future directions for clinical applications of iPS cells in treating degenerative diseases and injuries.
    • The ongoing development of novel reprogramming methods and therapeutic protocols.
    • Perspectives on the global landscape of stem cell research and innovation, particularly in Japan.